All three pathways are now meaningfully engaged
Lets face it, none of us love EHRs, but they have become an integral and ubiquitous tool in the practice of medicine
But the private market brings additional concerns
Journal of Clinical Endocrinology & Metabolism, 106 (3), 650-663
We connect you with licensed providers who understand the nuances of GLP-1 therapy and how it interacts with other treatments
"From a patient perspective, the bubble will not burst, and the drugs will not disappear, but we are reaching a point here where for GLP-1s, where vanity and health have collided and have really created a market that was being truly transformative for patients, for health systems, and for everybody," said Ronte